PFKFB3 is a critical regulator of neutrophil metabolism and function in rheumatoid arthritis - Fresneda Alarcon, Michele; Abdullah, Genna Ali; Nolan, Andrew; Linford, Christina; Phelan, Marie M; Wright, Helen L (medRxiv, 2023)
Neutrophils are key effector leukocytes of the innate immune system and play a pivotal role in defending the host against microbial infections. Recent studies have identified a crucial link between glycolysis and neutrophil cellular functions. Using human neutrophils, we have investigated the intricate relationship between glycolysis, extracellular glucose availability, and the enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), in the regulation of reactive oxygen species (ROS) and neutrophil extracellular trap (NET) production. We have identified that PFKFB3 activity is a key regulator of neutrophil ROS and NET production, cytotoxic molecules which are both implicated in the pathogenesis of immune-mediated inflammatory diseases such as rheumatoid arthritis (RA). Targeted inhibition of PFKFB3 expression blocked the production of ROS and NETs in a dose-dependent manner in both RA and HC neutrophils (p<0.01). RA neutrophils were more sensitive to lower concentrations of PFKFB3 inhibition. We also demonstrated that RA neutrophils retain ROS and NET production in culture conditions which mimic the low glucose environments encountered in the RA synovial joint. By dissecting the intricate interplay between PFKFB3, glycolysis, and neutrophil effector functions, this study advances the understanding of the molecular mechanisms governing innate immune responses and identifies PFKF3B as a potential therapeutic target for conditions characterized by dysregulated neutrophil activity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMFA was funded by a Versus Arthritis and Masonic Charitable Fund PhD scholarship (Grant No. 22193). GA was funded by a University of Liverpool CIMA MRes scholarship and a Dunhill Medical Trust and University of Liverpool PhD Scholarship. AN was funded by a Connect Immune Research and The Lorna & Yuti Chernajovsky Biomedical Research Foundation Grant (Grant No. 22925). HLW was funded by a Versus Arthritis Career Development Fellowship (Grant No. 21430). The equipment and software licences used in the Shared Research Facility for NMR metabolomics were funded by the MRC (Grant No. MR/M009114/1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the University of Liverpool Central University Research Ethics Committee C and NRES Committee North West (Greater Manchester West, Manchester, UK) for respectively the isolation of neutrophils from HC and RA blood. All participants gave written, informed consent in accordance with the declaration of Helsinki.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data presented in this manuscript are available upon reasonable request to the corresponding author.